Arcturus Therapeutics Holdings Inc (ARCT)
10.00
+0.57
(+6.04%)
USD |
NASDAQ |
Apr 02, 12:52
Arcturus Therapeutics Holdings Shareholders Equity (Quarterly): 240.98M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals Inc | 68.50M |
| Novavax Inc | -623.84M |
| Sangamo Therapeutics Inc | 22.77M |
| Capricor Therapeutics Inc | 145.46M |
| bluebird bio Inc | -31.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 344.07M |
| Total Liabilities (Quarterly) | 103.09M |
| Current Ratio | 4.672 |
| Net Debt Paydown Yield | 0.87% |